Repeat
dispensing of course already exists and this creates a great opportunity
for patients to talk to someone about their health, given their
next appointment with a doctor may be anything up to six months
away.
But if simple problems exist, that could be fixed with a dosage
change or changing the directions for administration the patient
has to be sent away for new prescriptions.
Models being put in place in the UK may negate this need by allowing
pharmacists to make these changes once a doctor has decided how
a patient is to be treated.
Moves are also afoot to allow pharmacist supplied non-prescription
items to be subsidised by their NHS. Tight constraints can be
expected on the Pharmaceutical Benefits Scheme (PBS) if the last
Federal Budget is any guide, so we probably cant expect
a similar move in Australia for some time.
The
Pharmaceutical Society of Australia (PSA) and the Pharmacy Guild
of Australia(PGA) have strongly pushed Pharmacy Self Care as a
way for pharmacists to get involved in the management of patients
with some chronic diseases.
Asthma and diabetes in particular have been targeted in pharmacies,
as areas where pharmacists can have some benefit.
Even in the public health system pharmacists are now expected
to play a role in hospital based priority health care programmes,
targeted at patients who are at risk of re-admission or long term
chronic health problems.
So were certainly part of the way there but still lagging
behind the UK in one way, i.e. the level of government support.
The management of chronic disease has become an increasingly large
part of the Federal Governments health programmes but these
have been almost entirely aimed at General Practitioners with
very little pharmacy input, outside of already existing pathways.
So there seems to be a difference in the vision for the Australian
health system and that of the UK.
The
Home Medicines Reviews (HMR) are a step in the right direction
in terms of getting pharmacists out of the dispensary.
Not everyone is happy with the way it has been implemented and
funded, and most pharmacists believe in particular that a greater
payment should be made for each review if a recent AusPharmList
poll is accurate.
This service could hold the greatest potential for pharmacists
to impact on the care of patients with chronic diseases and it
will be interesting to see how strongly these are promoted in
the coming months as the system comes fully online.
The Medications Assistance Service being rolled out by the PSA
may see a privately funded service for more basic medication concerns
to complement the more in-depth HMR scheme as discussed in a previous
article.
Technicians
are growing in importance all the time, as an efficient means
of freeing up scarce pharmacists for patient contact and management
functions.
Yet we still lag well behind the eight to one, technician to pharmacist
ratio, that is common in the UK.
In some parts of Australia, there are even artificial limits placed
on the number of technicians a pharmacist can employ.
This will surely need to change.
The UK has introduced a system of pharmacists screening prescriptions
on clinical grounds, and then leaving all dispensing, and responsibility
for accuracy to accredited technicians.
It will be interesting to see if we are this brave in Australia.
This
week in a meeting with Hospital Pharmacists, the NSW Health Minister
asked where the profession would be in five years time.
We bravely suggested items such as pharmacist prescribing, automated
dispensing, and greater convergence between professional groups.
The over-riding factor in how these sorts of measures can be implemented
may well the vision of health administrators, if they are prepared
to bite the bullet and look to overseas for inspiration.
|